This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Julie Su
Principal Scientist at Bristol-Myers Squibb


Julie did her graduate work with Anna Marie Pyle at Columbia University, focusing on the folding of large catalytic RNAs. She then carried out postdoctoral work in Susan Lindquist’s lab at Whitehead Institute, using yeast as a model for characterizing the disruption of cellular pathways caused by misfolding of alpha synuclein. She joined Bristol Myers Squibb in 2009 and works in Discovery, utilizing in vitro selection methods to identify biologic leads for therapeutic targets.

Agenda Sessions

  • Engineering Acidic pH Selective mAbs Targeting VISTA

    On Demand
  • Inducible Activation of Antibodies to Enhance Therapeutic Index